Skip to main content
. 2009 Mar 18;75(6):1337–1346. doi: 10.1124/mol.109.054833

Fig. 8.

Fig. 8.

VK1 metabolism in HLM is substantially attenuated by an array of selective CYP4F2 chemical inhibitors. TAO was included as a negative control. Reported values were determined from triplicate VK1 activity assays; error bars denote standard deviations.